Subject must be able to take oral medication and to maintain a fast as required for  hours before and  hour after alisertib administration
Willing to fast for  hours before and  hours after Oradoxel administration
Ability to swallow oral medications and maintain an empty stomach state for  hours prior to the MLN dose and for  hour following administration
Ability to swallow oral medications and maintain an empty stomach state for two hours prior to the TAK- dose and for one hour following administration
Must be able to take oral medication and to maintain a fast as required for  hours before and  hour after capsule(s) administration
Subject must be able to take oral medication and to maintain a fast, as is required for  hours before and  hour after alisertib (MLN) administration
According to current guidelines, patients must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration; these guidelines may change pending results from an ongoing food effects study
Patients must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration
Inability to swallow oral medication or to maintain a fast as required for  hours before and  hour after MLN administration or any condition that would modify small bowel absorption of oral medications, including malabsorption, or resection of pancreas or upper bowel
Ability to swallow oral medications and maintain an empty stomach state for  hours prior to the MLN dose and for  hour following administration
Inability to swallow oral medication or to maintain a fast as required for  hours before and  hour after MLN administration or any condition that would modify small bowel absorption of oral medications, including malabsorption, or resection of pancreas or upper bowel
Patient must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration
Able and willing to swallow and absorb orally administered medications and maintain a fast as required before and after MLN administration
Subject must be able to take oral medication and to maintain a fast as required before and after MLN administration
Subjects must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration
Subjects must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration.
According to current guidelines, patients must be able to take oral medication and to maintain a fast as required for  hours before and  hour after MLN administration; these guidelines may change pending results from an ongoing food effects study
Inability to swallow oral medication or to maintain a fast as required for  hours before and  hour after MLN administration or any condition that would modify small bowel absorption of oral medications, including malabsorption, or resection of pancreas or upper bowel
